Silence Therapeutics plc (SLN) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2022: $173.0K2023: $56.0K2024: $211.0K2025: $55.0K$55.0K
2022Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$55.0K-73.9%
2024$211.0K+276.8%
2023$56.0K-67.6%
2022$173.0K